These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 10514095

  • 1. Participation of prostate apoptosis response-4 in degeneration of dopaminergic neurons in models of Parkinson's disease.
    Duan W, Zhang Z, Gash DM, Mattson MP.
    Ann Neurol; 1999 Oct; 46(4):587-97. PubMed ID: 10514095
    [Abstract] [Full Text] [Related]

  • 2. Absence of prostate apoptosis response-4 protein in substantia nigra of Parkinson's disease autopsies.
    Moos T, Jensen PH.
    Acta Neuropathol; 2004 Jan; 107(1):23-6. PubMed ID: 13680279
    [Abstract] [Full Text] [Related]

  • 3. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L, Garris BL, Garris DR, Lau YS.
    Neuroscience; 2006 Jun 19; 140(1):67-76. PubMed ID: 16533572
    [Abstract] [Full Text] [Related]

  • 4. Participation of par-4 in the degeneration of striatal neurons induced by metabolic compromise with 3-nitropropionic acid.
    Duan W, Guo Z, Mattson MP.
    Exp Neurol; 2000 Sep 19; 165(1):1-11. PubMed ID: 10964480
    [Abstract] [Full Text] [Related]

  • 5. Evidence for the involvement of Par-4 in ischemic neuron cell death.
    Culmsee C, Zhu Y, Krieglstein J, Mattson MP.
    J Cereb Blood Flow Metab; 2001 Apr 19; 21(4):334-43. PubMed ID: 11323519
    [Abstract] [Full Text] [Related]

  • 6. Osteopontin is elevated in Parkinson's disease and its absence leads to reduced neurodegeneration in the MPTP model.
    Maetzler W, Berg D, Schalamberidze N, Melms A, Schott K, Mueller JC, Liaw L, Gasser T, Nitsch C.
    Neurobiol Dis; 2007 Mar 19; 25(3):473-82. PubMed ID: 17188882
    [Abstract] [Full Text] [Related]

  • 7. Attenuation of MPTP-induced neurotoxicity and locomotor dysfunction in Nucling-deficient mice via suppression of the apoptosome pathway.
    Teng X, Sakai T, Liu L, Sakai R, Kaji R, Fukui K.
    J Neurochem; 2006 May 19; 97(4):1126-35. PubMed ID: 16686692
    [Abstract] [Full Text] [Related]

  • 8. Hexokinase II gene transfer protects against neurodegeneration in the rotenone and MPTP mouse models of Parkinson's disease.
    Corona JC, Gimenez-Cassina A, Lim F, Díaz-Nido J.
    J Neurosci Res; 2010 Jul 19; 88(9):1943-50. PubMed ID: 20143419
    [Abstract] [Full Text] [Related]

  • 9. Regional expression of Par-4 mRNA and protein after fluid percussion brain injury in the rat.
    Dhillon HS, Dong GX, Yurek DM, Estus S, Rangnekar VM, Dendle P, Prasad RM.
    Exp Neurol; 2001 Jul 19; 170(1):140-8. PubMed ID: 11421591
    [Abstract] [Full Text] [Related]

  • 10. Expression of S-100 protein is related to neuronal damage in MPTP-treated mice.
    Muramatsu Y, Kurosaki R, Watanabe H, Michimata M, Matsubara M, Imai Y, Araki T.
    Glia; 2003 May 19; 42(3):307-13. PubMed ID: 12673835
    [Abstract] [Full Text] [Related]

  • 11. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease.
    Anglade P, Vyas S, Javoy-Agid F, Herrero MT, Michel PP, Marquez J, Mouatt-Prigent A, Ruberg M, Hirsch EC, Agid Y.
    Histol Histopathol; 1997 Jan 19; 12(1):25-31. PubMed ID: 9046040
    [Abstract] [Full Text] [Related]

  • 12. alpha -Synucleinopathy and selective dopaminergic neuron loss in a rat lentiviral-based model of Parkinson's disease.
    Lo Bianco C, Ridet JL, Schneider BL, Deglon N, Aebischer P.
    Proc Natl Acad Sci U S A; 2002 Aug 06; 99(16):10813-8. PubMed ID: 12122208
    [Abstract] [Full Text] [Related]

  • 13. p53 protein, interferon-gamma, and NF-kappaB levels are elevated in the parkinsonian brain.
    Mogi M, Kondo T, Mizuno Y, Nagatsu T.
    Neurosci Lett; 2007 Feb 27; 414(1):94-7. PubMed ID: 17196747
    [Abstract] [Full Text] [Related]

  • 14. Role of nuclear transcription factor kappa B (NF-kappaB) for MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahyropyridine)-induced apoptosis in nigral neurons of mice.
    Aoki E, Yano R, Yokoyama H, Kato H, Araki T.
    Exp Mol Pathol; 2009 Feb 27; 86(1):57-64. PubMed ID: 19027004
    [Abstract] [Full Text] [Related]

  • 15. Hsp70 gene transfer by adeno-associated virus inhibits MPTP-induced nigrostriatal degeneration in the mouse model of Parkinson disease.
    Dong Z, Wolfer DP, Lipp HP, Büeler H.
    Mol Ther; 2005 Jan 27; 11(1):80-8. PubMed ID: 15585408
    [Abstract] [Full Text] [Related]

  • 16. Rotenone induces oxidative stress and dopaminergic neuron damage in organotypic substantia nigra cultures.
    Testa CM, Sherer TB, Greenamyre JT.
    Brain Res Mol Brain Res; 2005 Mar 24; 134(1):109-18. PubMed ID: 15790535
    [Abstract] [Full Text] [Related]

  • 17. Granulocyte-macrophage colony-stimulating factor promotes survival of dopaminergic neurons in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced murine Parkinson's disease model.
    Kim NK, Choi BH, Huang X, Snyder BJ, Bukhari S, Kong TH, Park H, Park HC, Park SR, Ha Y.
    Eur J Neurosci; 2009 Mar 24; 29(5):891-900. PubMed ID: 19245369
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of Parkinson's disease-associated alpha-synucleinA53T by recombinant adeno-associated virus in mice does not increase the vulnerability of dopaminergic neurons to MPTP.
    Dong Z, Ferger B, Feldon J, Büeler H.
    J Neurobiol; 2002 Oct 24; 53(1):1-10. PubMed ID: 12360578
    [Abstract] [Full Text] [Related]

  • 19. Granulocyte-colony stimulating factor is neuroprotective in a model of Parkinson's disease.
    Meuer K, Pitzer C, Teismann P, Krüger C, Göricke B, Laage R, Lingor P, Peters K, Schlachetzki JC, Kobayashi K, Dietz GP, Weber D, Ferger B, Schäbitz WR, Bach A, Schulz JB, Bähr M, Schneider A, Weishaupt JH.
    J Neurochem; 2006 May 24; 97(3):675-86. PubMed ID: 16573658
    [Abstract] [Full Text] [Related]

  • 20. Correlation between levels of pigment epithelium-derived factor and vascular endothelial growth factor in the striatum of patients with Parkinson's disease.
    Yasuda T, Fukuda-Tani M, Nihira T, Wada K, Hattori N, Mizuno Y, Mochizuki H.
    Exp Neurol; 2007 Aug 24; 206(2):308-17. PubMed ID: 17604022
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.